A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

DNA analyst Yvonne "Missy" Woods pleaded guilty to four felonies (cybercrime, perjury, attempting to influence a public ...

BGI Group, one of the country's leading gene sequencing firms, is stepping up efforts to turn its life-science research and ...

Abu Dhabi launches AI-powered virtual human twin project to drive early diagnosis, precision medicine and preventive ...

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the ...

Data presented during ICCBH 2026 showed that improvements in tibial-femoral angle (TFA), a measure of lower extremity alignment, continued ...

Natera delivers robust revenue growth, raising 2026 guidance to $2.74–$2.82 billion, but remains unprofitable. Read more on ...

The link between biological aging and early-onset cancer risk offers crucial insights into generational health trends and ...

GC Genome, which entered the KOSDAQ market in June of last year, is accelerating its leap toward becoming a global precision medicine company as it marks its first anniversary since listing. Building ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its clinical development programs for the treatment of children with achondroplasia will be shared in an oral presentation ...